Increased peripheral neutrophil:lymphocyte ratios predict shorter GBM patient survival62 and intratumoral neutrophils promote GBM malignancy in part through S100A4-mediated activation of glioblastoma stem cell (GSC) proliferation, invasion, and resistance to anti-VEGF therapy33,63,64. The gene discussed is S100A4; the disease is glioblastoma.